glp-1 diabetes GLP-1R and The role of GLP1 receptor

By either sequential or concurrent administration of low doses of two agents, one a PDE-5 inhibitor and one a melanocortin receptor agonist, it has been found that a therapeutic effect equal to or greater than that achieved with a single high dose of either agent given as monotherapy can be obtained, without the side effects incident to high dose administration of either agent as monotherapy

ROS can oxidize cysteine residues allowing formation of disulfide bridges with one another or with GSH leading to S-glutathionylation

ccRCC cells are highly sensitive to the consumption of glutamine or cysteine, and the use of erastin, L-buthionine-S, or R-sulfoximine (BSO) can induce cell death by inhibiting GSH synthesis in ccRCC cells in a concentration-dependent manner (87)

Effect of estrogen on musculoskeletal performance and injury risk

How does drinking more water help reduce water retention

Bulman, C